AI assistant
GlaxoSmithKline PLC — Major Shareholding Notification 2010
Mar 16, 2010
5262_mrq_2010-03-16_b0b3d7a6-bfd1-4273-af1a-b22def389a30.zip
Major Shareholding Notification
Open in viewerOpens in your device viewer
PAGEBREAK
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934 (Amendment No. 1 )*
Redpoint Bio Corporation (1)
(Name of Issuer)
Common Stock, No Par Value
(Title of Class of Securities)
09060J106
(CUSIP Number)
William J. Mosher, GlaxoSmithKline One Franklin Plaza P.O. Box 7929, FP2355 Philadelphia, PA 19101
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
March 12, 2010
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box: o
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.
- The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
PAGEBREAK
CUSIP No. 09060J106
| 1. | NAMES OF REPORTING PERSONS. GlaxoSmithKline plc | |
|---|---|---|
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) | |
| (a) o | ||
| (b) o | ||
| 3. | SEC USE ONLY | |
| 4. | SOURCE OF FUNDS (SEE INSTRUCTIONS) | |
| 5. | CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) | |
| o | ||
| 6. | CITIZENSHIP OR PLACE OF ORGANIZATION | |
| England and Wales | ||
| 7. | SOLE VOTING POWER | |
| NUMBER OF | 7,455,689 | |
| SHARES | 8. | SHARED VOTING POWER |
| BENEFICIALLY | ||
| OWNED BY | 0 | |
| EACH | 9. | SOLE DISPOSITIVE POWER |
| REPORTING | ||
| PERSON | 7,455,689 | |
| WITH | 10. | SHARED DISPOSITIVE POWER |
| 0 | ||
| 11. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |
| 7,455,689 (2) (3) | ||
| 12. | CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | |
| o | ||
| 13. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) | |
| 9.3%(4) | ||
| 14. | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | |
| CO |
PAGEBREAK
Schedule 13D/A Continued
CUSIP No. 09060J106
ITEM 2. Identity and Background
The citizenship of each officer and director of GlaxoSmithKline plc is set forth in Schedule 1.
Footnotes:
| (1) | Redpoint Bio Corporation was formerly known as Robcor Properties, Inc. |
|---|---|
| (2) | Shares held of record by S.R. One, Limited, a wholly owned subsidiary of the Reporting Person |
| issued as of March 12, 2010 | |
| (3) | Warrant held of record by S.R. One, Limited, a wholly owned subsidiary of the Reporting |
| Person, expired as of March 12, 2010 | |
| (4) | Based on 79,838,693 shares of Common Stock as of March 12, 2010 |
Folio /Folio
PAGEBREAK
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| Date: March 16, 2010 | GlaxoSmithKline plc | |
|---|---|---|
| By: | /s/ Victoria Whyte | |
| Name: | Victoria Whyte | |
| Title: | Deputy Company Secretary |
Folio /Folio
PAGEBREAK
SCHEDULE 1
| Name | Business Address | Principal Occupation or Employment | Citizenship |
|---|---|---|---|
| Board of Directors | |||
| Andrew Witty | 980 Great West Road Brentford Middlesex, England TW8 9GS | Chief Executive Officer | British |
| Julian Heslop | 980 Great West Road Brentford Middlesex, England TW8 9GS | Chief Financial Officer | British |
| Dr. Moncef Slaoui | 709 Swedeland Road King of Prussia, PA 19046 | Executive Director Chairman Research & Development | Belgian |
| Sir Christopher Gent | 980 Great West Road Brentford Middlesex, England TW8 9GS | Company Director | British |
| Dr. Stephanie Burns | 980 Great West Road Brentford Middlesex, England TW8 9GS | Company Director | USA |
| Lawrence Culp | 980 Great West Road Brentford Middlesex, England TW8 9GS | Company Director | USA |
| Sir Crispin Davis | 980 Great West Road Brentford Middlesex, England TW8 9GS | Company Director | British |
| Sir Deryck Maughan | 980 Great West Road Brentford Middlesex, England TW8 9GS | Company Director | British |
| Dr. Daniel Podolsky | 980 Great West Road Brentford Middlesex, England TW8 9GS | Company Director | USA |
| Mr James Murdoch | 980 Great West Road Brentford Middlesex, England TW8 9GS | Company Director | British |
| Tom de Swaan | 980 Great West Road Brentford Middlesex, England TW8 9GS | Company Director | Dutch |
Folio /Folio
PAGEBREAK
| Name | Business Address | Principal Occupation or Employment | Citizenship |
|---|---|---|---|
| Sir Robert Wilson | 980 Great West Road Brentford Middlesex, England TW8 9GS | Company Director | British |
| Professor Sir Roy Anderson | 980 Great West Road Brentford Middlesex, England TW8 9GS | Company Director | British |
| Corporate Executive | |||
| Team | |||
| Andrew Witty | 980 Great West Road Brentford Middlesex, England TW8 9GS | Chief Executive Officer | British |
| Julian Heslop | 980 Great West Road Brentford Middlesex, England TW8 9GS | Chief Financial Officer | British |
| Daniel Troy | One Franklin Plaza Philadelphia, PA 19102 | Senior Vice President & General Counsel | USA |
| John Clarke | One Franklin Plaza Philadelphia, PA 19102 | President Consumer Healthcare | New Zealand |
| Marc Dunoyer | GSK Building 6-15, Sendagaya 4 chome, Shibuya-ku, Tokyo 151-8566 | President Asia Pacific / Japan | French |
| Abbas Hussain | 980 Great West Road Brentford Middlesex, England TW8 9GS | President, Emerging Markets | British |
| Duncan Learmouth | 980 Great West Road Brentford Middlesex, England TW8 9GS | Senior Vice President, Global Communications | British |
| William Louv | One Franklin Plaza Philadelphia, PA 19102 | Chief Information Officer | USA |
| Daniel J. Phelan | One Franklin Plaza Philadelphia, PA 19102 | Chief of Staff | USA |
| Claire Thomas | 980 Great West Road Brentford Middlesex, England TW8 9GS | Senior Vice President, Human Resources | British |
Folio /Folio
PAGEBREAK
| Name | Business Address | Principal Occupation or Employment | Citizenship |
|---|---|---|---|
| David Pulman | Five Moore Drive PO Box 13398 Research Triangle Park North Carolina 27709 | President, Global Manufacturing & Supply | British |
| Dr. Moncef Slaoui | 709 Swedeland Road | ||
| King of Prussia, PA | |||
| 19046 | Executive Director Chairman, Research and Development | Belgian | |
| David Redfern | 980 Great West Road Brentford Middlesex, England TW8 9GS | Chief Strategy Officer | British |
| Jean Stéphenne | Rue de lInstitut 89 | ||
| B-1330 Rixensart | |||
| Belgium | Chairman, President and General Manager, Biologicals | Belgian | |
| Edward Gray | 980 Great West Road Brentford Middlesex, England TW8 9GS | President, Pharmaceuticals Europe | British |
| Simon Bicknell | 980 Great West Road Brentford Middlesex, England TW8 9GS | Senior Vice President, Company Secretary & Compliance Officer | British |
| Deirdre Connolly | Five Moore Drive PO Box 13398 Research Triangle Park North Carolina 27709 | President, Pharmaceuticals, North America | USA |
Folio /Folio